jurgenfr Globus Medical ( NYSE: GMED ) is up ~8% in after-hours trading Tuesday after raising its 2024 guidance and releasing Q3 financial results that beat on both lines . The medical device company now sees full-year revenue of $2.49B to $2.
5B. Consensus is $2.48B.
Non-GAAP fully diluted earnings per.
